PDF icon Download PDF
Dtsch Med Wochenschr 2000; 125(48): 1471-1474
DOI: 10.1055/s-2000-8662
Aktuelle Diagnostik & Therapie
© Georg Thieme Verlag Stuttgart · New York

Klinik und Diagnostik der Hepatitis C

L. Leifeld, U. Spengler, T. Sauerbruch
  • Medizinische Universitätsklinik und Poliklinik I - Allgemeine Innere Medizin (Direktor: Prof. Dr. T. Sauerbruch), Rheinische Friedrich-Wilhelms-Universität Bonn
Further Information

Publication History

Publication Date:
31 December 2000 (online)

Also available ateRef
   Permissions and Reprints
Preview

Bei der Hepatitis C handelt es sich um eine weltweit verbreitete Infektion, die in einer Leberzirrhose oder in der Entwicklung eines hepatozellulären Karzinoms münden kann. Die Klinik ist häufig uncharakteristisch oder asymptomatisch, so dass die Diagnose in der Regel nur mittels serologischer Testverfahren gestellt werden kann. Als Suchtest ist hierbei der ELISA die Methode der Wahl, der von der Polymerase Kettenreaktion (PCR) zur Bestätigung ergänzt wird.

Literatur

  • 1 WHO .The world health report 1998. Life in the 21 st century - A vision for all. 1998.
    Search in Google Scholar
  • 2 Kuhnl P, Seidl S, Stangel W. et al . Antibody to hepatitis C virus in German blood donors.   Lancet. 1989;  2 324
    Search in Google Scholar
  • 3 Heintges T, Mohr L, Niederau C. Epidemiology and clinical features of chronic viral hepatitis.  Dtsch Med Wschr. 1994;  119 1365-1370
    Search in Google Scholar
  • 4 Heintges T, Wands J R. Hepatitis C virus: Epidemiology and transmission.   Hepatology. 1997;  26 521-526
    Search in Google Scholar
  • 5 Dienstag J L. Sexual and perinatal transmission of hepatitis C.   Hepatology. 1997;  26 66s-70s
    Search in Google Scholar
  • 6 Soto B, Rodrigo L, Garcia-Bengoechea M. et al . Heterosexual transmission of hepatitis C virus and the possible role of coexistent human immunodeficiency virus infection in the index case. A multicentre study of 423 pairings.   J Intern Med. 1994;  236 515-519
    Search in Google Scholar
  • 7 Gordon S C, Patel A H, Kulesza G W. et al . Lack of evidence for the heterosexual transmission of hepatitis C.   Am J Gastroenterol. 1992;  87 1849-1851
    Search in Google Scholar
  • 8 Wyld R, Robertson J R, Brettle R P. et al . Absence of hepatitis C virus transmission but frequent transmission of HIV-1 from sexual contact with doubly-infected individuals.   J Infect. 1997;  35 163-166
    Search in Google Scholar
  • 9 Bresters D, Mauser-Bunschoten E P, Reesink H W. et al . Sexual transmission of hepatitis C virus.   Lancet. 1993;  342 210-211
    Search in Google Scholar
  • 10 Conry-Cantilena C, VanRaden M, Gibble J. et al . Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection.   N Engl J Med. 1996;  334 1691-1696
    Search in Google Scholar
  • 11 Ohto H, Terazawa S, Sasaki N. et al . Transmission of hepatitis C virus from mothers to infants. The Vertical Transmission of Hepatitis C Virus Collaborative Study Group.   N Engl J Med. 1994;  330 744-750
    Search in Google Scholar
  • 12 Zanetti A R, Tanzi E, Romano L. et al . Multicenter trial on mother-to-infant transmission of GBV-C virus. The Lombardy Study Group on Vertical/Perinatal Hepatitis Viruses Transmission.  J Med Virol. 1998;  54 107-112
    Search in Google Scholar
  • 13 Granovsky M O, Minkoff H L, Tess B H. et al . Hepatitis C virus infection in the mothers and infants cohort study.   Pediatrics. 1998;  102 355-359
    Search in Google Scholar
  • 14 Health NIo . National Institutes of Health Consensus Development Conference Panel statement: Management of hepatitis C.   Hepatology. 1997;  26 2s-10s
    Search in Google Scholar
  • 15 EASL International Consensus Conference on Hepatitis C . Paris, 26-28, February 1999, Consensus Statement. European Association for the Study of the Liver.  J Hepatol. 1999;  30 956-961
    Search in Google Scholar
  • 16 Puro V, Petrosillo N, Ippolito G. Risk of hepatitis C seroconversion after occupational exposures in health care workers. Italian Study Group on Occupational Risk of HIV and Other Bloodborne Infections.   Am J Infect Control. 1995;  23 273-277
    Search in Google Scholar
  • 17 Hasan F, Askar H, Al Khalidi J, Al Shamali M, Al Kalaoui M, Al Nakib B. Lack of transmission of hepatitis C virus following needlestick accidents.   Hepatogastroenterology. 1999;  46 1678-1681
    Search in Google Scholar
  • 18 Hamid S S, Farooqui B, Rizvi Q. et al . Risk of transmission and features of hepatitis C after needlestick injuries.   Infect Control Hosp Epidemiol. 1999;  20 63-64
    Search in Google Scholar
  • 19 Mizuno Y, Suzuki K, Mori M. et al . Study of needlestick accidents and hepatitis C virus infection in healthcare workers by molecular evolutionary analysis.   J Hosp Infect. 1997;  35 149-154
    Search in Google Scholar
  • 20 Mitsui T, Iwano K, Masuko K. et al . Hepatitis C virus infection in medical personnel after needlestick accident.  Hepatology. 1992;  16 1109-1114
    Search in Google Scholar
  • 21 Arai Y, Noda K, Enomoto N. et al . A prospective study of hepatitis C virus infection after needlestick accidents.   Liver. 1996;  16 331-334
    Search in Google Scholar
  • 22 Pawlotsky J M, Ben Yahia M, Andre  C. et al . Immunological disorders in C virus chronic active hepatitis: A prospective case-control study.   Hepatology. 1994;  19 841-848
    Search in Google Scholar
  • 23 Agnello V, Chung R T, Kaplan L M. A role for hepatitis C virus infection in type II cryoglobulinemia.   N Engl J Med. 1992;  327 1490-1495
    Search in Google Scholar
  • 24 Lamprecht P, Schnabel A, Gross W L. Hepatitis C virus-associated cryoglobulinemic vasculitis. Physiopathology, diagnosis and therapy.   Dtsch Med Wschr. 1998;  123 637-642
    Search in Google Scholar
  • 25 Ferri C, Caracciolo F, Zignego A L. et al . Hepatitis C virus infection in patients with non-Hodgkin"s lymphoma.   Br J Haematol. 1994;  88 392-394
    Search in Google Scholar
  • 26 Mazzaro C, Zagonel V, Monfardini S. et al . Hepatitis C virus and non-Hodgkin"s lymphomas.   Br J Haematol. 1996;  94 544-550
    Search in Google Scholar
  • 27 Neumann A U, Lam N P, Dahari H. et al . Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy.   Science. 1998;  282 103-107
    Search in Google Scholar
  • 28 Tsai S L, Chen Y M, Chen M H. et al . Hepatitis C virus variants circumventing cytotoxic T lymphocyte activity as a mechanism of chronicity.   Gastroenterology. 1998;  115 954-965
    Search in Google Scholar
  • 29 Rehermann B, Chang K M, McHutchinson J. et al . Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients.  J Virol. 1996;  70 7092-7102
    Search in Google Scholar
  • 30 Lechmann M, Ihlenfeldt H G, Braunschweiger I. et al . T- and B-cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and in healthy anti-hepatitis C virus - positive blood donors without viremia.   Hepatology. 1996;  24 790-795
    Search in Google Scholar
  • 31 Botarelli P, Brunetto M R, Minutello M A. et al . T-lymphocyte response to hepatitis C virus in different clinical courses of infection.  Gastroenterology. 1993;  104 580-587
    Search in Google Scholar
  • 32 Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups.   Lancet. 1997;  349 825-832
    Search in Google Scholar
  • 33 Kenny-Walsh E. Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group.   N Engl J Med. 1999;  340 1228-1233
    Search in Google Scholar
  • 34 Serfaty L, Aumaitre H, Chazouilleres O. et al . Determinants of outcome of compensated hepatitis C virus-related cirrhosis.   Hepatology. 1998;  27 1435-1440
    Search in Google Scholar
  • 35 Tong M J, el Farra N S, Reikes A R, Co R L. Clinical outcomes after transfusion-associated hepatitis C.   N Engl J Med. 1995;  332 1463-1466
    Search in Google Scholar
  • 36 El-Serag H B, Mason A C. Rising incidence of hepatocellular carcinoma in the United States.   N Engl J Med. 1999;  340 745-750
    Search in Google Scholar
  • 37 Shakil A O, Conry-Cantilena C, Alter H J. et al . Volunteer blood donors with antibody to hepatitis C virus: Clinical, biochemical, virologic, and histologic features. The Hepatitis C Study Group.   Ann Intern Med. 1995;  123 330-337
    Search in Google Scholar
  • 38 Naito M, Hayashi N, Hagiwara H. et al . Serum hepatitis C virus RNA quantity and histological features of hepatitis C virus carriers with persistently normal ALT levels.   Hepatology. 1994;  19 871-875
    Search in Google Scholar
  • 39 Alberti A, Morsica G, Chemello L. et al . Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV.   Lancet. 1992;  340 697-698
    Search in Google Scholar
  • 40 Sangiovanni A, Morales R, Spinzi G. et al . Interferon alfa treatment of HCV RNA carriers with persistently normal transaminase levels: A pilot randomized controlled study.  Hepatology. . 1998;  27 853-856
    Search in Google Scholar
  • 41 Pawlotsky J M, Lonjon I, Hezode C. et al . What strategy should be used for diagnosis of hepatitis C virus infection in clinical laboratories?.  Hepatology. 1998;  27 1700-1702
    Search in Google Scholar
  • 42 Roggendorf M, Lu M, Meisel H, Riffelmann M, Schreier E, Viazov S. Rational use of diagnostic tools in hepatitis C.   J Hepatol. 1996;  24 26-34
    Search in Google Scholar
  • 43 Long G S, Bacon B R, Bisceglie A M. Interpreting serologic tests for hepatitis C virus infection: Balancing cost and clarity.  Cleve Clin J Med. 1996;  63 264268
    Search in Google Scholar
  • 44 Damen M, Cuypers H T, Zaaijer H L. et al . International collaborative study on the second EUROHEP HCV-RNA reference panel.   J Virol Methods. 1996;  58 175-185
    Search in Google Scholar
  • 45 Lok A S, Gunaratnam N T. Diagnosis of hepatitis C.  Hepatology. 1997;  26 48S-56S
    Search in Google Scholar
  • 46 Roth W K, Lee J H, Ruster B, Zeuzem S. Comparison of two quantitative hepatitis C virus reverse transcriptase PCR assays.   J Clin Microbiol. 1996;  34 261-264
    Search in Google Scholar
  • 47 Pawlotsky J M, Martinot-Peignoux M, Poveda J D. et al . Quantification of hepatitis C virus RNA in serum by branched DNA-based signal amplification assays.   J Virol Methods. 1999;  79 227-235
    Search in Google Scholar
  • 48 Takeuchi T, Katsume A, Tanaka T. et al . Real-time detection system for quantification of hepatitis C virus genome.   Gastroenterology. 1999;  116 636-642
    Search in Google Scholar
  • 49 Kawai S, Yokosuka O, Kanda T, Imazeki F, Maru Y, Saisho H. Quantification of hepatitis C virus by TaqMan PCR: Comparison with HCV Amplicor Monitor assay.   J Med Virol. 1999;  58 121-126
    Search in Google Scholar
  • 50 Huber K R, Sebesta C, Bauer K. Detection of common hepatitis C virus subtypes with a third-generation enzyme immunoassay.   Hepatology. 1996;  24 471-473
    Search in Google Scholar
  • 51 Fischer H P, Willsch E, Bierhoff E, Pfeifer U. Histopathologic findings in chronic hepatitis C.   J Hepatol. 1996;  24 35-42
    Search in Google Scholar
  • 52 Bukh J, Miller R H, Purcell R H. Genetic heterogeneity of hepatitis C virus: Quasispecies and genotypes.   Semin Liver Dis. 1995;  15 41-63
    Search in Google Scholar
  • 53 Simmonds P, Alberti A, Alter H J. et al . A proposed system for the nomenclature of hepatitis C viral genotypes.   Hepatology. 1994;  19 1321-1324
    Search in Google Scholar

Korrespondenz

Dr. med. Ludger Leifeld

Medizinische Universitäts-Klinik und Poliklinik I

Allgemeine Innere Medizin

Rheinische Friedrich-Wilhelms-Universität Bonn

Sigmund-Freud-Straße 25

53105 Bonn

Phone: 0228/287-5383

Fax: 0228/287-4323

Email: l.leifeld@uni-bonn.de